# Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)

> **NCT07123155** · PHASE2 · RECRUITING · sponsor: **Shionogi** · enrollment: 45 (estimated)

## Conditions studied

- Pompe Disease

## Interventions

- **DRUG:** S-606001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07123155
- **Lead sponsor:** Shionogi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-30
- **Primary completion:** 2027-08-08
- **Final completion:** 2027-08-08
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07123155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07123155, "Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07123155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*